Screening colonoscopy yields among adults ages 45 to 49 after lowering the colon cancer screening age
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Jul-2025 10:10 ET (9-Jul-2025 14:10 GMT/UTC)
E-cigarette warnings, especially those highlighting health harms, effectively discourage vaping without causing unintended consequences like increased cigarette smoking, according to a meta-analysis of 24 studies by University of North Carolina Lineberger Comprehensive Cancer Center researchers and their colleagues.
In a randomized clinical trial, Mass General Brigham researchers and their colleagues found that combining inavolisib with the standard two-drug treatment resulted in longer patient survival and slower cancer progression for those with the PIK3CA gene mutation.
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025 – propelling a new era of precision medicine in breast cancer.
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary question, finding that the investigational combination it tested did not significantly extend overall survival compared to standard of care treatments. Importantly, the phase 3 trial’s rapid development and implementation, coupled with its successful enrollment of a group of patients broadly representative of the larger U.S. population, establish Pragmatica-Lung as a paradigm-shifting model for the design and conduct of future large randomized studies.